
The Mission
Key Opinion Leaders
International
Advisory Board
Initiatives
Discuss a case
Journal Scan
Latest News
Education Hub
Gallery
Papers from the IBDENC Region
Key articles from high impact journals in last month
November 2021
Combination of sarcopenia and high visceral fat predict poor outcomes in patients with Crohn's disease
Boparai G, Kedia S, Kandasamy D, Sharma R, Madhusudhan KS, Dash NR, Sahu P, Pal S, Sahni P, Panwar R, Vuyyuru SK, Kante B, Yadav DP, Mouli VP, Makharia G, Ahuja V
Published Oct 2021, in the European journal of clinical nutrition
Antibiotics for induction and maintenance of remission in ulcerative colitis: systematic review and meta-analysis
Mishra S, Jha DK, Singh AK, Kumar-M P, Patil A, Sharma V
Published Oct 2021, in the Expert review of Gastroenterology & Hepatology
Optimization of infliximab therapy in inflammatory bowel disease using a dashboard approach-an Indian experience
Dave MB, Dherai AJ, Desai DC, Mould DR, Ashavaid TF
Published Jan 2021, in the European journal of clinical pharmacology
Tubercular Pleural Effusion in a Patient of Ulcerative Colitis Treated With Tofacitinib
Mishra S, Kumar Singh A, Kopp C, Jena A, Sharma V.
Published Sep 2021, in the Inflammatory bowel diseases
Epidemiology of Inflammatory Bowel Diseases in Nepal
Paudel MS, Khanal A, Shrestha B, Purbey B, Paudel BN, Shrestha G, Thapa J, Dewan KR, Gurung R,
Published Jul 2021, in the Cureus
Inflammatory bowel disease in Bahrain: single-center experience
Abdulla M, Al Saeed M, Fardan RH, Alalwan HF, Ali Almosawi ZS, Almahroos AF, Al Qamish J.
Published Jul 2017, in the Clinical and Experimental Gastroenterology
Mimics of Inflammatory Bowel Disease in Clinical Practice
Mayank Jain
Published Oct 2020, in the Tropical Gastroenterology
Prevalence of polymorphisms in thiopurine metabolism and association with adverse outcomes: a South Asian region-specific systematic review and meta-analysis
Jena A, Jha DK, Kumar-M P, Kasudhan KS, Kumar A, Sarwal D, Mishra S, Singh AK, Bhatia P, Patil A, Sharma V.
Published Apr 2021, in the Expert review of clinical pharmacology.
Azathioprine with Allopurinol Is a Promising First‑Line Therapy for Infammatory Bowel Diseases
Elsa L. S. A. van Liere, Ahmed B. Bayoumy, Chris J. J. Mulder, Ben Warner, Bu Hayee, Bilal A. Mateen, Jonathan D. Nolan, Nanne K. H. de Boer, Simon H. C. Anderson, Azhar R. Ansari
Published Oct 2020, in the Digestive Diseases and Sciences